← Search

Data · dataset · 2026

Identification and evaluation of a bioactive peptide, QUB-3195, from the skin secretion of <i>Phyllomedusa sauvagei</i>

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32640195.v1

Antimicrobial resistance has emerged as a greater hazard to public health than other issues throughout the past several years and antimicrobial peptides have been identified as viable therapeutics against drug-resistant bacteria due to their broad-spectrum action and low propensity to induce drug resistance.

Description

Peptides secreted from amphibian skins have a great range of bioactive functions and thus there has been a growing interest in peptides as clinical therapeutic agents.

The Dermaseptin peptides are a superfamily of antimicrobial peptides. They have a variety of low-cytotoxic antimicrobial and anticancer properties.In this study, QUB-3195, a novel Dermaseptin peptide, was isolated from the skin secretion of Phyllomedusa sauvagei. A cDNA library was constructed by using the isolation mRNA from frog skin secretion and ‘shotgun’ cloning, through the use of which the mature peptide sequence was deduced.

Read the rest (2 more)

The purified peptide was obtained by reversed-phase high performance liquid chromatography. In this research, QUB-3195 was found to exhibit a wide range of antimicrobial activity against tested Gram-negative bacteria, Gram-positive bacteria, and yeast. The MIC and MBC values for both tested bacteria were determined to be 1 μM.For the yeast strain, the MIC and MBC were both 16 μM. In addition, QUB-3195 inhibited a human lung cancer cell line (H838).

The half minimal inhibitory concentration (IC50, µM) of QUB-3195 was 39.9 µM. However, the peptide showed a weak inhibitory function of haemolysis activity with a HC50 value of 287.7 µM. In summary, due to its strong antibacterial and anticancer properties, QUB-3195 is a good option for developing novel medications for use in clinical settings. Also, with further modifications and experiments, QUB-3195 may be found to have better antimicrobial and anticancer functions in future studies.<br><br><i>Thesis is embargoed until 31st December 2029</i>.<br><br>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75%
Provenance · 3 source records, 9 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3264019512 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3264019512 d agoJSON v1
DMU Figshareoai:figshare.com:article/3264019512 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title